Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Oz Leading Indicator Improves, But Still Negative

May 27 2009

The Leading Index for Australia showed some positives in May, but don’t expect a recovery until the final quarter, say Westpac economists.


No Talecris No Reason To Be Negative On CSL

May 26 2009

The company’s proposed Talecris acquisition in the US now appears unlikely to proceed but with solid earnings growth still expected brokers remain positive on the outlook for CSL.


It’s Swine Flu Versus Talecris Trouble For CSL

May 25 2009

Any move by the Australian government to increase its flu vaccine supplies should benefit CSL but US authorities seem ready to block the Talecris deal.


Positive Trends For Oz Private Hospital Players

May 25 2009

A positive trend in private health insurance membership is a good sign for private hospital operators, reports Southern Cross Equities.


CBA Questions Budget Pessimism

May 22 2009

Commonwealth Bank believes the Australian federal budget forecast of an 18.5% drop in business investment is way too panicked.


Oz Consumers Still See Higher Unemployment, Lower Inflation

May 21 2009

The May survey by Westpac has in essence revealed no major changes from April about consumers’ views on unemployment or inflation.


Is It Too Early, Too Soon For James Hardie?

May 21 2009

Stockbroking analysts suggest it remains too early to look into buying James Hardie shares.


Oz Consumers Disappointed With Government Budget

May 20 2009

After a strong gain in April the Westpac-Melbourne Institute survey of Consumer Sentiment fell in May in response to a Federal Budget seen as offering little to consumers.


Oz Biotechs Up 88% So Far This Year

May 20 2009

Southern Cross Equities analyst Stuart Roberts reports the come back of risk appetite has been good for biotechnology stocks this year.


Billabong’s Earnings Wipeout

May 19 2009

Tougher retail conditions has seen surfwear group Billabong cut earnings guidance and raise equity, the result being brokers no longer see the stock’s share price premium as justified.



Analyse The Market From A Different Angle